FLT1 and neoplasm: Mechanistically, we discovered that VEGF-B binds to FGFR1, induces FGFR1/VEGFR1 complex formation, inhibits FGF2-induced Erk activation, and thereby suppresses FGF2-driven angiogenesis and tumor growth.